擺脫市場錯殺 台康跌停衝到漲停 - 工商時報
郭台銘購疫苗有進展，今天中午向衛生福利部食品藥物管理署遞件完成。郭台銘砸50億元入股的台康生技（6589）業績來源不僅只有做高端疫苗新冠疫苗的原液，還有CDMO業務及新藥授權金等等，午盤擺脫市場錯殺的陰霾，打開跌停，直衝漲停板鎖住159.5元，振幅高達20%。
Lin mark this message contains true information
｜originally written by Lin
郭台銘向衛生福利部食品藥物管理署遞件完成，打開跌停，直衝漲停板鎖住159.5元，
References
https://ctee.com.tw/news/stocks/468462.htmlhttps://ctee.com.tw/news/stocks/468462.html
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.